双歧杆菌选择计数方法的研究进展

综述了近年来双歧杆菌选择计数方面的研究进展。介绍了国外报道的几种应用效果较好的选择计数培养基,提出了这方面需要进一步开展的工作与想法。     

低聚异麦芽糖改善小鼠胃肠道功能的研究

以二月龄雄性BALB／c小鼠为实验对象,研究了IMO－50与IMO－90调节胃肠道菌群的功能,结果表明：连续给予IMO－50或IMO－9014天后,小鼠胃肠疲乏内双歧杆菌数量显著增加。以二月龄雄性BALB／c小鼠为实验对象,以复方地芬诺酯建立的便秘模型为参比对照,研究IMO-50IMO－90的润畅通便功能,结果表明：在连续给予受试物14天后,便秘小鼠的肠推进率显著提高,首便、首黑便时间明显缩短,8小时排便重量显著增加。提示IMO－50和IMO－90均可改善小鼠胃肠道功能。     

Novel probiotic-fermented milk with angiotensin I-converting enzyme inhibitory peptides produced by Bifidobacterium bifidum MF 20/5

In previous research, we have demonstrated that Bifidobacterium bifidum MF 20/5 fermented milk possessed stronger angiotensin converting enzyme (ACE) inhibitory activity than other lactic acid bacteria, including Lactobacillus helveticus DSM 13137, which produces the hypotensive casokinins Ile-Pro-Pro (IPP) and Val-Pro-Pro (VPP). The aim of this study is to investigate the ACE-inhibitory peptides released in B. bifidum MF 20/5 fermented milk. The novel ACE-inhibitory peptide LVYPFP (IC₅₀ = 132 μM) is reported here for the first time. Additionally, other bioactive peptides such as the ACE-inhibitor LPLP (IC₅₀ = 703 μM), and the antioxidant VLPVPQK were identified. Moreover, the peptide and amino acid profiles, the ACE-inhibitory activity (ACEi), pH, and degree of hydrolysis of the fermented milk were determined and compared with those obtained in milk fermented by L. helveticus DSM 13137. The sequences of the major bioactive peptides present in fermented milk of B. bifidum and L. helveticus were identified and quantified. B. bifidum released a larger amount of peptides than L. helveticus but no IPP or VPP were detected in B. bifidum fermented milk. Also the lactotripeptide concentrations and ACEi were higher in L. helveticus fermented milk when the pH was maintained at 4.6. This may represent a technical advantage for B. bifidum that reduces the pH at a slow enough rate to facilitate the peptide generation without the need for pH control. Thus these findings show the potential for the use of this probiotic strain to produce fermented milk with a wider range of health benefits including reduction of blood pressure.     

Hypocholesterolaemic effect of yoghurt containing Bifidobacterium pseudocatenulatum G4 or Bifidobacterium longum BB536

The effect of a yoghurt supplement containing Bifidobacterium pseudocatenulatum G4 or Bifidobacterium longum BB536 on plasma lipids, lipid peroxidation and the faecal excretion of bile acids was examined in rats fed a cholesterol-enriched diet. After 8 weeks, the rats in the positive control (PC) group who were fed the cholesterol-enriched diet showed significant increases in plasma total cholesterol (TC), low-density lipoprotein (LDL) cholesterol, and malondialdehyde (MDA). However, groups fed a cholesterol-enriched diet supplemented with yoghurt containing B. pseudocatenulatum G4 or B. longum BB536 had significantly lower plasma TC, LDL-C, very-low-density lipoprotein (VLDL) cholesterol, and MDA than had the PC group after 8 weeks of treatment. In addition, faecal excretion of bile acids was markedly increased in the rats fed the yoghurt containing B. pseudocatenulatum G4 or B. longum BB536 as compared to the PC and NC groups.     

豆类双歧杆菌发酵饮料的研制

以糊化赤豆和去腥大豆浆为原料，添加１％的葡萄糖和２％的乳糖等成分，用双歧杆菌、保加利亚乳杆菌和嗜热乳酸链球菌作混合发酵剂，接种量为３％，发酵后可制得含有活菌的豆类发酵饮料。赤豆和大豆的产地对产品质量无影响     

益生菌种的应用和市场趋势

本文对全球益生菌种的最新研究及市场趋势作一简要阐述,同时,也对丹尼斯克公司在益生菌种的此前沿领域应用研究进展作了介绍.     

双歧杆菌及其保健机理

本文从双歧杆菌产生有机酸、抑制肠道腐生菌生长出发,对其抗癌作用、对肝脏及人体代谢的保健作用、改善维生素代谢、防止便秘、提高免疫机能以及降低清血胆固醇作用等进行了较详细的论述,确认了双歧杆菌的优良保健性能。     

Comparison of the sensitivity of commercial strains and infant isolates of bifidobacteria to antibiotics and bacteriocins

Eighteen bifidobacteria, six isolated from infant feces and 12 commercial strains (of which 10 were purchased from the American Type Culture Collection), were tested for sensitivity to 14 antibiotics and four bacteriocins including nisin A, nisin Z, pediocin PA-1 and mutacin B-Ny266. All bacteria were resistant to vancomycin, kanamycin, neomycin and streptomycin. Infant isolates were more sensitive than commercial strains to cloxacillin, ampicillin, chloramphenicol, tetracycline, rifampicin and novobiocin. Sensitivity to bacteriocins determined by a microplate assay varied widely. Generally, nisin A was the most effective bacteriocin followed by nisin Z and mutacin B-Ny266. Pediocin PA-1 appeared to have no inhibition at 70 μg mL⁻¹. Commercial strains showed relatively variable sensitivity to bacteriocins compared to infant isolates, which were inhibited within a narrow range of bacteriocin concentration. Bacteriocin tolerance could be easily gained by prolonging the exposure time. Death–time curves and transmission electron microscopy (TEM) of logarithmic and stationary cells of two strains (Bifidobacterium adolescentis ATCC 15704 and infant isolate Bifidobacterium sp. RBL67) incubated with twice the minimum inhibitory concentration of nisin A and nisin Z for 3 h revealed that log-phase cells were more sensitive than stationary-phase cells. TEM showed that the cell membrane is the most likely site of bactericidal effects of nisin.     

Bifidobacterium carbohydrases-their role in breakdown and synthesis of (potential) prebiotics

There is an increasing interest to positively influence the human intestinal microbiota through the diet by the use of prebiotics and/or probiotics. It is anticipated that this will balance the microbial composition in the gastrointestinal tract in favor of health promoting genera such as Bifidobacterium and Lactobacillus. Carbohydrates like non-digestible oligosaccharides are potential prebiotics. To understand how these bacteria can grow on these carbon sources, knowledge of the carbohydrate-modifying enzymes is needed. Little is known about the carbohydrate-modifying enzymes of bifidobacteria. The genome sequence of Bifidobacterium adolescentis and Bifidobacterium longum biotype longum has been completed and it was observed that for B. longum biotype longum more than 8% of the annotated genes were involved in carbohydrate metabolism. In addition more sequence data of individual carbohydrases from other Bifidobacterium spp. became available. Besides the degradation of (potential) prebiotics by bifidobacterial glycoside hydrolases, we will focus in this review on the possibilities to produce new classes of non-digestible oligosaccharides by showing the presence and (transglycosylation) activity of the most important carbohydrate modifying enzymes in bifidobacteria. Approaches to use and improve carbohydrate-modifying enzymes in prebiotic design will be discussed.     

新疆喀什地区维吾尔族母乳源双歧杆菌分离筛选及其益生特性分析

采用多重聚合酶链式反应指纹图谱结合16S rRNA基因测序技术对新疆喀什地区维吾尔族母乳分离的双歧杆菌进行鉴定和遗传差异分析,并检测常规生理生化和糖代谢表型特征,同时测试菌株对6 种常见病原菌和3 种母乳源条件致病菌的抑菌性能和对胃肠液的耐受性。结果显示,15 份母乳样品中共分离15 株双歧杆菌,测序结果将菌株归属于3 个种以及2 个亚种,包括8 株假小链双歧杆菌（Bifidobacterium pseudocatenulatum）、2 株短双歧杆菌（B. breve）、2 株长双歧杆菌长亚种（B. longum subsp. longum）和3 株长双歧杆菌婴儿亚种（B. longum subsp. infantis）。抑菌实验表明,15 株测试菌株中,隶属于B. pseudocatenulatum的4 株菌MY92、MY75-1、MY72、MY81的抑菌谱更广,抑菌能力更强;胃肠液耐受性实验表明菌株MY92无论在模拟胃液还是模拟肠液中存活率均最高,分别达到20.37%和0.302%。基于以上描述特性,MY92作为一株有效的益生菌株,具有潜在的利用价值,为后期进一步作为防止婴幼儿腹泻辅助制剂的开发提供参考。